Leerink Partnrs Has Bearish Forecast for Danaher Q1 Earnings

Key Points

• Leerink Partnrs has lowered its Q1 2026 earnings per share (EPS) forecast for Danaher Corporation to $2.12, slightly down from the previous estimate of $2.15.
• Danaher recently reported a quarterly revenue of $5.94 billion, surpassing analyst expectations, and its earnings per share for the previous quarter was $1.80.
• The company plans to pay a quarterly dividend of $0.32 per share on October 31st, representing an annualized dividend yield of 0.6%.

Danaher Corporation (NYSE:DHR - Free Report) - Investment analysts at Leerink Partnrs cut their Q1 2026 EPS estimates for Danaher in a research report issued on Monday, October 13th. Leerink Partnrs analyst P. Souda now forecasts that the conglomerate will post earnings of $2.12 per share for the quarter, down from their prior estimate of $2.15. The consensus estimate for Danaher's current full-year earnings is $7.63 per share. Leerink Partnrs also issued estimates for Danaher's Q2 2026 earnings at $1.97 EPS.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.

A number of other analysts also recently commented on DHR. Rothschild Redb downgraded shares of Danaher from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 8th. Guggenheim reissued a "buy" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Wells Fargo & Company decreased their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Rothschild & Co Redburn reissued a "neutral" rating and set a $220.00 price objective (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Finally, Evercore ISI boosted their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a report on Tuesday, October 7th. Seventeen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $244.60.

Danaher Trading Up 0.1%

Shares of Danaher stock opened at $206.32 on Thursday. Danaher has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company's 50-day simple moving average is $201.18 and its 200-day simple moving average is $197.19. The firm has a market cap of $147.73 billion, a price-to-earnings ratio of 43.90, a price-to-earnings-growth ratio of 2.94 and a beta of 0.77.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of DHR. GAMMA Investing LLC lifted its position in shares of Danaher by 22.2% in the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate's stock worth $1,871,000 after buying an additional 1,660 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Danaher by 4.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 207,169 shares of the conglomerate's stock worth $42,470,000 after acquiring an additional 7,907 shares during the period. Ritholtz Wealth Management increased its holdings in shares of Danaher by 8.8% in the 1st quarter. Ritholtz Wealth Management now owns 6,469 shares of the conglomerate's stock worth $1,326,000 after acquiring an additional 522 shares during the period. Sowell Financial Services LLC acquired a new stake in shares of Danaher in the 1st quarter worth about $1,442,000. Finally, Sagespring Wealth Partners LLC increased its holdings in shares of Danaher by 14.0% in the 1st quarter. Sagespring Wealth Partners LLC now owns 4,535 shares of the conglomerate's stock worth $930,000 after acquiring an additional 556 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company's stock.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's dividend payout ratio is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.